LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial Of DAY101 Monotherapy Versus Standard Of Care Chemotherapy In Patients With Pediatric Low-Grade Glioma Harboring An Activating RAF Alteration Requiring First-Line Systemic Therapy
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Holly Lindsay
Study ID
Protocol Number: 22-1751
More information available at ClinicalTrials.gov: NCT05566795
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers